Related Experiment Video

Updated: Mar 22, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.8K

Sarcoidosis in celiac disease: A page written by genetic variants in IL-18 miRNAs target site?

Raffaella Mormile1

  • 1Division of Pediatrics and Neonatology, Moscati Hospital, Aversa, Italy.

Medical Hypotheses
|April 12, 2016
PubMed

Insights

This study explores the link between sarcoidosis and celiac disease (CD), suggesting common genetic factors in Interleukin-18 (IL-18) miRNA target sites may contribute to both autoimmune conditions.

Area of Science:

  • Immunology
  • Genetics
  • Molecular Biology

Background:

  • Sarcoidosis is a chronic granulomatous disease linked to Interleukin-18 (IL-18) and specific microRNA (miRNA) profiles.
  • MicroRNAs regulate gene expression and are implicated in autoimmune disease susceptibility, including modulating Th1 cytokines like IL-18.
  • Sarcoidosis is associated with autoimmune disorders such as celiac disease (CD), an immune-mediated condition triggered by gluten intolerance.

Purpose of the Study:

  • To investigate the potential shared genetic basis between sarcoidosis and celiac disease.
  • To explore the role of Interleukin-18 (IL-18) and its miRNA regulation in the pathogenesis of both conditions.
  • To identify common genetic variants in IL-18 miRNA target sites as a potential unifying factor.

Main Methods:

  • Review of existing literature on sarcoidosis, celiac disease, IL-18, and miRNA.
  • Analysis of genetic data focusing on miRNA target sites related to IL-18.
  • Comparative study of miRNA expression profiles in patients with sarcoidosis and CD.

Main Results:

  • IL-18 plays a significant role in the inflammation associated with both sarcoidosis and gluten exposure in CD.
  • Altered miRNA expression is a characteristic feature in both sarcoidosis and CD patients.
  • Evidence suggests a potential overlap in the genetic regulation of IL-18 via miRNAs in these diseases.

Conclusions:

  • Common genetic variants in IL-18 miRNA target sites may underlie the co-occurrence of sarcoidosis and celiac disease.
  • Further research into IL-18-miRNA interactions is crucial for understanding the pathogenesis of these autoimmune diseases.
  • This hypothesis provides a novel perspective on the shared etiology of sarcoidosis and CD.

More Related Videos

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma10:21

Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma

Published on: September 20, 2024

945
Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis10:27

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

25.1K

Related Concept Videos

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
65
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
75
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
106